CC
NVAX icon

Curian Capital’s Novavax NVAX Stock Holding History

Curian Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,965
Closed -$406K – 613
2013
Q4 		$406K Sell
3,965
-4,153
-51% -$293K 0.01% 520
2013
Q3 		$511K Buy
8,118
+162
+2% +$9.12K 0.01% 504
2013
Q2 		$326K Buy
+7,956
New +$345K 0.01% 533

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Curian Capital's NVAX Position: Q1 2014 in Review

Curian Capital sold out of Novavax (NVAX) in Q1 2014, closing a stake of 3,965 shares — an estimated $406K sold.

Curian Capital first reported a position in NVAX in Q2 2013 and held it in 3 quarters. The position peaked at $511K in Q3 2013. 141 funds tracked by Wall St. Rank hold NVAX as of Q1 2014.

  • Curian Capital reported no remaining Novavax position as of Q1 2014 after selling out during the quarter.
  • Curian Capital sold 3,965 Novavax shares in Q1 2014, an estimated $406K.
  • Curian Capital first reported a position in Novavax in Q2 2013 and held it in 3 quarters.
  • Curian Capital's Novavax position peaked at $511K in Q3 2013.
  • 141 funds tracked by Wall St. Rank held Novavax as of Q1 2014.

Based on Curian Capital's 13F filing for Q1 2014, filed 12 May 2014.